The healthcare sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, hospitals, and health insurers. AI analysis examines pipeline progress, FDA approvals, revenue diversification, and profitability metrics from quarterly SEC filings.
Best Healthcare Stocks to Buy in 2026
Top-rated healthcare stocks ranked by AI confidence score. Dual AI analysis (Claude + ChatGPT) based on SEC 10-K and 10-Q filings. Last Updated: April 2026
MDXG
Confidence
92%
DXCM
Confidence
90%
CRMD
Confidence
90%
LLY
Confidence
90%
INVA
Confidence
88%
IDXX
Confidence
87%
MEDP
Confidence
87%
CPRX
Confidence
86%
SYK
Confidence
86%
INSP
Confidence
85%
NBIX
Confidence
84%
ELTP
Confidence
84%
All Healthcare Stocks (837)
| Ticker | Company | AI Rating | Confidence | Action |
|---|---|---|---|---|
| SKVI | SKINVISIBLE, INC. | STRONG SELL | 98% | View Analysis → |
| SIGY | Sigyn Therapeutics, Inc. | STRONG SELL | 98% | View Analysis → |
| PIIIW | P3 Health Partners Inc. | STRONG SELL | 98% | View Analysis → |
| FCHS | First Choice Healthcare Solutions, Inc. | STRONG SELL | 98% | View Analysis → |
| SKYE | Skye Bioscience, Inc. | STRONG SELL | 97% | View Analysis → |
| QNCX | Quince Therapeutics, Inc. | STRONG SELL | 97% | View Analysis → |
| QCLS | Q/C TECHNOLOGIES, INC. | STRONG SELL | 97% | View Analysis → |
| PRPH | ProPhase Labs, Inc. | STRONG SELL | 97% | View Analysis → |
| NIMU | NON INVASIVE MONITORING SYSTEMS INC /FL/ | STRONG SELL | 96% | View Analysis → |
| KAYS | Kaya Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| RGPX | REGENEREX PHARMA, INC. | STRONG SELL | 96% | View Analysis → |
| LUDG | LUDWIG ENTERPRISES, INC. | STRONG SELL | 96% | View Analysis → |
| IRME | IR-Med, Inc. | STRONG SELL | 96% | View Analysis → |
| GCAN | Greater Cannabis Company, Inc. | STRONG SELL | 96% | View Analysis → |
| ENDV | ENDONOVO THERAPEUTICS, INC. | STRONG SELL | 96% | View Analysis → |
| EMMA | Emmaus Life Sciences, Inc. | STRONG SELL | 96% | View Analysis → |
| EDGM | Edgemode, Inc. | STRONG SELL | 96% | View Analysis → |
| CPMD | CANNAPHARMARX, INC. | STRONG SELL | 96% | View Analysis → |
| CPHI | CHINA PHARMA HOLDINGS, INC. | STRONG SELL | 96% | View Analysis → |
| CLSDQ | Clearside Biomedical, Inc. | STRONG SELL | 96% | View Analysis → |
| CLCS | Cell Source, Inc. | STRONG SELL | 96% | View Analysis → |
| CELUW | Celularity Inc | STRONG SELL | 96% | View Analysis → |
| CDIOW | Cardio Diagnostics Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| CBIH | Cannabis Bioscience International Holdings, Inc. | STRONG SELL | 96% | View Analysis → |
| BZYR | BURZYNSKI RESEARCH INSTITUTE INC | STRONG SELL | 96% | View Analysis → |
| BRTX | BioRestorative Therapies, Inc. | STRONG SELL | 96% | View Analysis → |
| BPTH | BIO-PATH HOLDINGS, INC. | STRONG SELL | 96% | View Analysis → |
| BKHAR | Black Hawk Acquisition Corp | STRONG SELL | 96% | View Analysis → |
| BIXT | BIOXYTRAN, INC | STRONG SELL | 96% | View Analysis → |
| BDPT | BIOADAPTIVES, INC. | STRONG SELL | 96% | View Analysis → |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC. | STRONG SELL | 96% | View Analysis → |
| ARMP | Armata Pharmaceuticals, Inc. | STRONG SELL | 96% | View Analysis → |
| AIM | AIM ImmunoTech Inc. | STRONG SELL | 96% | View Analysis → |
| SNOA | Sonoma Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SMNRW | Semnur Pharmaceuticals, Inc. | STRONG SELL | 95% | View Analysis → |
| SLNCF | Silence Therapeutics plc | STRONG SELL | 95% | View Analysis → |
| SILO | Silo Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| SGP | SpyGlass Pharma, Inc. | STRONG SELL | 95% | View Analysis → |
| SERA | SERA PROGNOSTICS, INC. | STRONG SELL | 95% | View Analysis → |
| SCLXW | Scilex Holding Co | STRONG SELL | 95% | View Analysis → |
| RVP | RETRACTABLE TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| RTGN | RetinalGenix Technologies Inc. | STRONG SELL | 95% | View Analysis → |
| RTEZ | REST EZ Inc. | STRONG SELL | 95% | View Analysis → |
| OTLC | Oncotelic Therapeutics, Inc. | STRONG SELL | 95% | View Analysis → |
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | STRONG SELL | 95% | View Analysis → |
| PTN | PALATIN TECHNOLOGIES INC | STRONG SELL | 95% | View Analysis → |
| PSTV | PLUS THERAPEUTICS, INC. | STRONG SELL | 95% | View Analysis → |
| PREM | Premier Air Charter Holdings Inc. | STRONG SELL | 95% | View Analysis → |
| PPCB | Propanc Biopharma, Inc. | STRONG SELL | 95% | View Analysis → |
| POSC | POSITRON CORP | STRONG SELL | 95% | View Analysis → |
| PMN | ProMIS Neurosciences Inc. | STRONG SELL | 95% | View Analysis → |
| PMI | Picard Medical, Inc. | STRONG SELL | 95% | View Analysis → |
| PLUR | Pluri Inc. | STRONG SELL | 95% | View Analysis → |
| PKTX | ProtoKinetix, Inc. | STRONG SELL | 95% | View Analysis → |
| PCSC | Perceptive Capital Solutions Corp | STRONG SELL | 95% | View Analysis → |
| PAVM | PAVmed Inc. | STRONG SELL | 95% | View Analysis → |
| NIKA | NIKA PHARMACEUTICALS, INC | STRONG SELL | 95% | View Analysis → |
| MDCXW | Medicus Pharma Ltd. | STRONG SELL | 95% | View Analysis → |
| MCUJF | MEDICURE INC | STRONG SELL | 95% | View Analysis → |
| MCLE | Medicale Corp. | STRONG SELL | 95% | View Analysis → |
| ISPC | iSpecimen Inc. | STRONG SELL | 95% | View Analysis → |
| BSPK | Bespoke Extracts, Inc. | STRONG SELL | 95% | View Analysis → |
| BQST | Bioquest Corp | STRONG SELL | 95% | View Analysis → |
| BFRGW | BullFrog AI Holdings, Inc. | STRONG SELL | 95% | View Analysis → |
| AXIM | AXIM BIOTECHNOLOGIES, INC. | STRONG SELL | 95% | View Analysis → |
| ASBPW | Aspire Biopharma Holdings, Inc. | STRONG SELL | 95% | View Analysis → |
| MRAI | Marpai, Inc. | STRONG SELL | 94% | View Analysis → |
| MGRX | MANGOCEUTICALS, INC. | STRONG SELL | 94% | View Analysis → |
| MCAGU | Mountain Crest Acquisition Corp. V | STRONG SELL | 94% | View Analysis → |
| MAIA | MAIA Biotechnology, Inc. | STRONG SELL | 94% | View Analysis → |
| LYRA | Lyra Therapeutics, Inc. | STRONG SELL | 94% | View Analysis → |
| JAGX | Jaguar Health, Inc. | STRONG SELL | 94% | View Analysis → |
| IVF | INVO Fertility, Inc. | STRONG SELL | 94% | View Analysis → |
| ITRM | Iterum Therapeutics plc | STRONG SELL | 94% | View Analysis → |
| GELS | Gelteq Ltd | SELL | 94% | View Analysis → |
| GALT | GALECTIN THERAPEUTICS INC | STRONG SELL | 94% | View Analysis → |
| ERNAW | Ernexa Therapeutics Inc. | STRONG SELL | 94% | View Analysis → |
| ENVB | Enveric Biosciences, Inc. | STRONG SELL | 94% | View Analysis → |
| ENSCW | Ensysce Biosciences, Inc. | STRONG SELL | 94% | View Analysis → |
| EMED | Electromedical Technologies, Inc | STRONG SELL | 94% | View Analysis → |
| EBRCZ | EBR Systems, Inc. | STRONG SELL | 94% | View Analysis → |
| CYTOF | Altamira Therapeutics Ltd. | SELL | 94% | View Analysis → |
| CYDY | CytoDyn Inc. | STRONG SELL | 94% | View Analysis → |
| CTRVP | Hepion Pharmaceuticals, Inc. | STRONG SELL | 94% | View Analysis → |
| CRGT | Cortigent, Inc. | SELL | 94% | View Analysis → |
| CPMV | Mosaic ImmunoEngineering Inc. | STRONG SELL | 94% | View Analysis → |
| CODX | Co-Diagnostics, Inc. | STRONG SELL | 94% | View Analysis → |
| CNBX | CNBX Pharmaceuticals Inc. | STRONG SELL | 94% | View Analysis → |
| CLNN | Clene Inc. | STRONG SELL | 94% | View Analysis → |
| CEROW | CERO THERAPEUTICS HOLDINGS, INC. | STRONG SELL | 94% | View Analysis → |
| CASIF | CASI Pharmaceuticals, Inc. | STRONG SELL | 94% | View Analysis → |
| CALC | CalciMedica, Inc. | STRONG SELL | 94% | View Analysis → |
| BUDZ | WEED, INC. | STRONG SELL | 94% | View Analysis → |
| BTAI | BioXcel Therapeutics, Inc. | STRONG SELL | 94% | View Analysis → |
| BIOE | Bio Essence Corp | STRONG SELL | 94% | View Analysis → |
| BGMSP | Bio Green Med Solution, Inc. | STRONG SELL | 94% | View Analysis → |
| BDRX | Biodexa Pharmaceuticals Plc | STRONG SELL | 94% | View Analysis → |
| AWHL | Aspira Women's Health Inc. | STRONG SELL | 94% | View Analysis → |
| APTOF | Aptose Biosciences Inc. | STRONG SELL | 94% | View Analysis → |
| ALZN | Alzamend Neuro, Inc. | STRONG SELL | 94% | View Analysis → |
| ALUR | ALLURION TECHNOLOGIES, INC. | STRONG SELL | 94% | View Analysis → |
| AKTX | Akari Therapeutics Plc | STRONG SELL | 94% | View Analysis → |
| AIMDW | Ainos, Inc. | STRONG SELL | 94% | View Analysis → |
| AGTX | Agentix Corp. | STRONG SELL | 94% | View Analysis → |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | STRONG SELL | 93% | View Analysis → |
| IMTH | AnTix Holdings, Inc. | STRONG SELL | 93% | View Analysis → |
| HCWB | HCW Biologics Inc. | STRONG SELL | 93% | View Analysis → |
| IOBT | IO Biotech, Inc. | STRONG SELL | 93% | View Analysis → |
| INTI | Inhibitor Therapeutics, Inc. | STRONG SELL | 93% | View Analysis → |
| INO | INOVIO PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| GCTK | Glucotrack, Inc. | STRONG SELL | 93% | View Analysis → |
| FTII | FutureTech II Acquisition Corp. | STRONG SELL | 93% | View Analysis → |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | STRONG SELL | 93% | View Analysis → |
| EXOZ | EXOZYMES INC. | STRONG SELL | 93% | View Analysis → |
| EVFM | Evofem Biosciences, Inc. | STRONG SELL | 93% | View Analysis → |
| ESLAW | Estrella Immunopharma, Inc. | STRONG SELL | 93% | View Analysis → |
| ENZN | ENZON PHARMACEUTICALS, INC. | STRONG SELL | 93% | View Analysis → |
| BCAB | BioAtla, Inc. | STRONG SELL | 93% | View Analysis → |
| AVHHL | AVITA Medical, Inc. | STRONG SELL | 93% | View Analysis → |
| ARTL | ARTELO BIOSCIENCES, INC. | STRONG SELL | 93% | View Analysis → |
| APVO | Aptevo Therapeutics Inc. | STRONG SELL | 93% | View Analysis → |
| SLDB | Solid Biosciences Inc. | STRONG SELL | 92% | View Analysis → |
| SINT | Sintx Technologies, Inc. | STRONG SELL | 92% | View Analysis → |
| POCI | PRECISION OPTICS CORPORATION, INC. | STRONG SELL | 92% | View Analysis → |
| PMHS | Polomar Health Services, Inc. | STRONG SELL | 92% | View Analysis → |
| PHGE | BiomX Inc. | STRONG SELL | 92% | View Analysis → |
| PGEN | PRECIGEN, INC. | STRONG SELL | 92% | View Analysis → |
| ORGS | Orgenesis Inc. | STRONG SELL | 92% | View Analysis → |
| ONMDW | OneMedNet Corp | STRONG SELL | 92% | View Analysis → |
| ODYY | Odyssey Health, Inc. | STRONG SELL | 92% | View Analysis → |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| IBO | IMPACT BIOMEDICAL INC. | STRONG SELL | 92% | View Analysis → |
| GTHP | GUIDED THERAPEUTICS INC | STRONG SELL | 92% | View Analysis → |
| GPLB | Green Planet Bio Engineering Co. Ltd. | STRONG SELL | 92% | View Analysis → |
| RENXF | Renalytix plc | STRONG SELL | 92% | View Analysis → |
| NVACW | Profusa, Inc. | STRONG SELL | 92% | View Analysis → |
| NUMD | Nu-Med Plus, Inc. | STRONG SELL | 92% | View Analysis → |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| MDXG | MIMEDX GROUP, INC. | STRONG BUY | 92% | View Analysis → |
| MDAIW | Spectral AI, Inc. | STRONG SELL | 92% | View Analysis → |
| MBRX | Moleculin Biotech, Inc. | STRONG SELL | 92% | View Analysis → |
| MBOT | Microbot Medical Inc. | STRONG SELL | 92% | View Analysis → |
| MANE | Veradermics, Inc | STRONG SELL | 92% | View Analysis → |
| LYEL | Lyell Immunopharma, Inc. | STRONG SELL | 92% | View Analysis → |
| INKT | MiNK Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| GH | Guardant Health, Inc. | STRONG SELL | 92% | View Analysis → |
| FEMY | FEMASYS INC | STRONG SELL | 92% | View Analysis → |
| ELTX | Elicio Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| EDIT | Editas Medicine, Inc. | STRONG SELL | 92% | View Analysis → |
| DWTX | Dogwood Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| DBVTF | DBV Technologies S.A. | STRONG SELL | 92% | View Analysis → |
| CVKD | Cadrenal Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CUBT | Curative Biotechnology Inc | SELL | 92% | View Analysis → |
| CRIS | CURIS INC | STRONG SELL | 92% | View Analysis → |
| CMND | Clearmind Medicine Inc. | SELL | 92% | View Analysis → |
| CLDX | Celldex Therapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CLDWW | Calidi Biotherapeutics, Inc. | STRONG SELL | 92% | View Analysis → |
| CINGW | Cingulate Inc. | STRONG SELL | 92% | View Analysis → |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | STRONG SELL | 92% | View Analysis → |
| BYSI | BeyondSpring Inc. | STRONG SELL | 92% | View Analysis → |
| BTCY | BIOTRICITY INC. | STRONG SELL | 92% | View Analysis → |
| BJDX | Bluejay Diagnostics, Inc. | STRONG SELL | 92% | View Analysis → |
| BIAFW | bioAffinity Technologies, Inc. | STRONG SELL | 92% | View Analysis → |
| BETRF | BetterLife Pharma Inc. | STRONG SELL | 92% | View Analysis → |
| BEATW | HeartBeam, Inc. | STRONG SELL | 92% | View Analysis → |
| BCDA | BioCardia, Inc. | STRONG SELL | 92% | View Analysis → |
| AZTR | Azitra, Inc. | STRONG SELL | 92% | View Analysis → |
| AVCRF | Avricore Health Inc. | SELL | 92% | View Analysis → |
| APLMW | Apollomics Inc. | SELL | 92% | View Analysis → |
| AMIX | Autonomix Medical, Inc. | STRONG SELL | 92% | View Analysis → |
| ALMS | ALUMIS INC. | SELL | 92% | View Analysis → |
| ALEC | Alector, Inc. | STRONG SELL | 92% | View Analysis → |
| NBY | NovaBay Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| MGTX | MeiraGTx Holdings plc | STRONG SELL | 91% | View Analysis → |
| INDP | Indaptus Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| FTRE | Fortrea Holdings Inc. | STRONG SELL | 91% | View Analysis → |
| EVMN | Evommune, Inc. | STRONG SELL | 91% | View Analysis → |
| DNABW | Ginkgo Bioworks Holdings, Inc. | STRONG SELL | 91% | View Analysis → |
| CVM | CEL SCI CORP | STRONG SELL | 91% | View Analysis → |
| CTOR | CITIUS ONCOLOGY, INC. | STRONG SELL | 91% | View Analysis → |
| CRDF | Cardiff Oncology, Inc. | STRONG SELL | 91% | View Analysis → |
| COCP | Cocrystal Pharma, Inc. | STRONG SELL | 91% | View Analysis → |
| CNSP | CNS Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| BOLT | Bolt Biotherapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| AURX | Nuo Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| ATRA | Atara Biotherapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| ATPC | Agape ATP Corp | STRONG SELL | 91% | View Analysis → |
| ATNM | Actinium Pharmaceuticals, Inc. | STRONG SELL | 91% | View Analysis → |
| ALGS | Aligos Therapeutics, Inc. | STRONG SELL | 91% | View Analysis → |
| SSKN | STRATA Skin Sciences, Inc. | STRONG SELL | 90% | View Analysis → |
| SNGX | SOLIGENIX, INC. | STRONG SELL | 90% | View Analysis → |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS, INC. | STRONG SELL | 90% | View Analysis → |
| PHAT | Phathom Pharmaceuticals, Inc. | STRONG SELL | 90% | View Analysis → |
| OTLK | Outlook Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| OSTX | OS Therapies Inc | STRONG SELL | 90% | View Analysis → |
| ONCO | Onconetix, Inc. | STRONG SELL | 90% | View Analysis → |
| NDRA | ENDRA Life Sciences Inc. | STRONG SELL | 90% | View Analysis → |
| LIMNW | Liminatus Pharma, Inc. | STRONG SELL | 90% | View Analysis → |
| LGVN | Longeveron Inc. | STRONG SELL | 90% | View Analysis → |
| KPTI | Karyopharm Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| JRSS | JRSIS HEALTH CARE Corp | STRONG SELL | 90% | View Analysis → |
| HURA | TuHURA Biosciences, Inc./NV | STRONG SELL | 90% | View Analysis → |
| GOSS | Gossamer Bio, Inc. | STRONG SELL | 90% | View Analysis → |
| RNTX | Rein Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| RGBPP | Regen BioPharma Inc | STRONG SELL | 90% | View Analysis → |
| NUWE | Nuwellis, Inc. | STRONG SELL | 90% | View Analysis → |
| MGX | Metagenomi Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| FOXOW | FOXO TECHNOLOGIES INC. | STRONG SELL | 90% | View Analysis → |
| FNCH | Finch Therapeutics Group, Inc. | STRONG SELL | 90% | View Analysis → |
| FHTX | Foghorn Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| FBLG | FibroBiologics, Inc. | STRONG SELL | 90% | View Analysis → |
| ELAB | PMGC Holdings Inc. | STRONG SELL | 90% | View Analysis → |
| DXCM | DEXCOM INC | STRONG BUY | 90% | View Analysis → |
| DRMAW | Dermata Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| DRIO | DarioHealth Corp. | STRONG SELL | 90% | View Analysis → |
| DMAC | DiaMedica Therapeutics Inc. | STRONG SELL | 90% | View Analysis → |
| DARE | Dare Bioscience, Inc. | STRONG SELL | 90% | View Analysis → |
| CYTK | CYTOKINETICS INC | STRONG SELL | 90% | View Analysis → |
| CYPH | CYPHERPUNK TECHNOLOGIES INC. | SELL | 90% | View Analysis → |
| CYCN | Cyclerion Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| CV | CapsoVision, Inc | STRONG SELL | 90% | View Analysis → |
| CTXR | Citius Pharmaceuticals, Inc. | STRONG SELL | 90% | View Analysis → |
| CRVO | CervoMed Inc. | STRONG SELL | 90% | View Analysis → |
| CRMD | CorMedix Inc. | BUY | 90% | View Analysis → |
| CRBU | Caribou Biosciences, Inc. | SELL | 90% | View Analysis → |
| CMPS | COMPASS Pathways plc | STRONG SELL | 90% | View Analysis → |
| CDTTW | CDT Equity Inc. | STRONG SELL | 90% | View Analysis → |
| BMRA | BIOMERICA INC | STRONG SELL | 90% | View Analysis → |
| BMEA | Biomea Fusion, Inc. | STRONG SELL | 90% | View Analysis → |
| BGLC | BioNexus Gene Lab Corp | STRONG SELL | 90% | View Analysis → |
| BDSX | BIODESIX INC | STRONG SELL | 90% | View Analysis → |
| AVTX | Avalo Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| ATYR | aTYR PHARMA INC | STRONG SELL | 90% | View Analysis → |
| ATXI | AVENUE THERAPEUTICS, INC. | STRONG SELL | 90% | View Analysis → |
| ATAI | Atai Beckley N.V. | SELL | 90% | View Analysis → |
| ASRT | Assertio Holdings, Inc. | STRONG SELL | 90% | View Analysis → |
| ANVS | Annovis Bio, Inc. | SELL | 90% | View Analysis → |
| LLY | ELI LILLY & Co | BUY | 90% | View Analysis → |
| ANL | Adlai Nortye Ltd. | SELL | 90% | View Analysis → |
| ANIX | Anixa Biosciences Inc | STRONG SELL | 90% | View Analysis → |
| ALXO | ALX ONCOLOGY HOLDINGS INC | STRONG SELL | 90% | View Analysis → |
| ALT | Altimmune, Inc. | SELL | 90% | View Analysis → |
| ALLR | Allarity Therapeutics, Inc. | STRONG SELL | 90% | View Analysis → |
| OCEA | Ocean Biomedical, Inc. | STRONG SELL | 89% | View Analysis → |
| NKTR | NEKTAR THERAPEUTICS | STRONG SELL | 89% | View Analysis → |
| JUNS | JUPITER NEUROSCIENCES, INC. | STRONG SELL | 89% | View Analysis → |
| IMUX | IMMUNIC, INC. | STRONG SELL | 89% | View Analysis → |
| IBRX | ImmunityBio, Inc. | STRONG SELL | 89% | View Analysis → |
| ENTX | Entera Bio Ltd. | SELL | 89% | View Analysis → |
| CNTB | Connect Biopharma Holdings Ltd | SELL | 89% | View Analysis → |
| CLRB | Cellectar Biosciences, Inc. | STRONG SELL | 89% | View Analysis → |
| BHVN | Biohaven Ltd. | STRONG SELL | 89% | View Analysis → |
| AQST | Aquestive Therapeutics, Inc. | SELL | 89% | View Analysis → |
| APYX | Apyx Medical Corp | SELL | 89% | View Analysis → |
| SPRY | ARS Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| SNTI | Senti Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| SLXNW | Silexion Therapeutics Corp | STRONG SELL | 88% | View Analysis → |
| SLS | SELLAS Life Sciences Group, Inc. | SELL | 88% | View Analysis → |
| SGMO | SANGAMO THERAPEUTICS, INC | STRONG SELL | 88% | View Analysis → |
| SCNX | Scienture Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| RVRC | Revium Rx. | STRONG SELL | 88% | View Analysis → |
| RVMDW | Revolution Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| QURE | uniQure N.V. | STRONG SELL | 88% | View Analysis → |
| QTIWW | QT IMAGING HOLDINGS, INC. | STRONG SELL | 88% | View Analysis → |
| PULM | Pulmatrix, Inc. | STRONG SELL | 88% | View Analysis → |
| PTIXW | Protagenic Therapeutics, Inc.new | STRONG SELL | 88% | View Analysis → |
| PRTA | PROTHENA CORP PUBLIC LTD CO | STRONG SELL | 88% | View Analysis → |
| PRAX | Praxis Precision Medicines, Inc. | STRONG SELL | 88% | View Analysis → |
| PMVP | PMV Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| PETVW | PetVivo Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OSRHW | OSR Holdings, Inc. | STRONG SELL | 88% | View Analysis → |
| OCGN | Ocugen, Inc. | STRONG SELL | 88% | View Analysis → |
| LUCD | Lucid Diagnostics Inc. | STRONG SELL | 88% | View Analysis → |
| LNSR | LENSAR, Inc. | STRONG SELL | 88% | View Analysis → |
| LNAI | Lunai Bioworks Inc. | STRONG SELL | 88% | View Analysis → |
| KALA | KALA BIO, Inc. | STRONG SELL | 88% | View Analysis → |
| INBX | Inhibrx Biosciences, Inc. | STRONG SELL | 88% | View Analysis → |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | STRONG SELL | 88% | View Analysis → |
| GNLX | GENELUX Corp | STRONG SELL | 88% | View Analysis → |
| RGNX | REGENXBIO Inc. | STRONG SELL | 88% | View Analysis → |
| RDGL | VIVOS INC | STRONG SELL | 88% | View Analysis → |
| NRXPW | NRX Pharmaceuticals, Inc. | STRONG SELL | 88% | View Analysis → |
| NOTV | Inotiv, Inc. | STRONG SELL | 88% | View Analysis → |
| MODD | Modular Medical, Inc. | STRONG SELL | 88% | View Analysis → |
| MIST | Milestone Pharmaceuticals Inc. | SELL | 88% | View Analysis → |
| MIRA | MIRA PHARMACEUTICALS, INC. | SELL | 88% | View Analysis → |
| MGNX | MACROGENICS INC | SELL | 88% | View Analysis → |
| MBIO | MUSTANG BIO, INC. | SELL | 88% | View Analysis → |
| IXHL | Incannex Healthcare Inc. | SELL | 88% | View Analysis → |
| IVEVF | Inventiva S.A. | SELL | 88% | View Analysis → |
| IRD | Opus Genetics, Inc. | SELL | 88% | View Analysis → |
| INVA | Innoviva, Inc. | BUY | 88% | View Analysis → |
| INSM | INSMED Inc | SELL | 88% | View Analysis → |
| INMB | Inmune Bio, Inc. | SELL | 88% | View Analysis → |
| GANX | Gain Therapeutics, Inc. | SELL | 88% | View Analysis → |
| FBRX | Forte Biosciences, Inc. | SELL | 88% | View Analysis → |
| FATE | FATE THERAPEUTICS INC | SELL | 88% | View Analysis → |
| EUDAW | EUDA Health Holdings Ltd | STRONG SELL | 88% | View Analysis → |
| EOLS | Evolus, Inc. | SELL | 88% | View Analysis → |
| ELUT | ELUTIA INC. | SELL | 88% | View Analysis → |
| ECOR | electroCore, Inc. | SELL | 88% | View Analysis → |
| DERM | Journey Medical Corp | SELL | 88% | View Analysis → |
| DCOY | Decoy Therapeutics Inc. | SELL | 88% | View Analysis → |
| DCGO | DocGo Inc. | SELL | 88% | View Analysis → |
| CRVS | Corvus Pharmaceuticals, Inc. | SELL | 88% | View Analysis → |
| COGT | Cogent Biosciences, Inc. | SELL | 88% | View Analysis → |
| CARM | Carisma Therapeutics Inc. | SELL | 88% | View Analysis → |
| BIVIW | BIOVIE INC. | SELL | 88% | View Analysis → |
| BBIO | BridgeBio Pharma, Inc. | SELL | 88% | View Analysis → |
| ARTV | Artiva Biotherapeutics, Inc. | SELL | 88% | View Analysis → |
| ARAY | ACCURAY INC | SELL | 88% | View Analysis → |
| APUS | Apimeds Pharmaceuticals US, Inc. | SELL | 88% | View Analysis → |
| ANTX | AN2 Therapeutics, Inc. | SELL | 88% | View Analysis → |
| TFX | TELEFLEX INC | SELL | 88% | View Analysis → |
| ANNX | Annexon, Inc. | SELL | 88% | View Analysis → |
| AMLX | Amylyx Pharmaceuticals, Inc. | SELL | 88% | View Analysis → |
| SRZNW | Surrozen, Inc./DE | STRONG SELL | 87% | View Analysis → |
| SGMT | Sagimet Biosciences Inc. | STRONG SELL | 87% | View Analysis → |
| PLX | Protalix BioTherapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| PCSA | Processa Pharmaceuticals, Inc. | STRONG SELL | 87% | View Analysis → |
| OMER | OMEROS CORP | STRONG SELL | 87% | View Analysis → |
| IDXX | IDEXX LABORATORIES INC /DE | STRONG BUY | 87% | View Analysis → |
| GUTS | FRACTYL HEALTH, INC. | SELL | 87% | View Analysis → |
| MTNB | Matinas BioPharma Holdings, Inc. | STRONG SELL | 87% | View Analysis → |
| MEDP | Medpace Holdings, Inc. | STRONG BUY | 87% | View Analysis → |
| ISCO | International Stem Cell CORP | SELL | 87% | View Analysis → |
| INM | InMed Pharmaceuticals Inc. | SELL | 87% | View Analysis → |
| ERAS | Erasca, Inc. | SELL | 87% | View Analysis → |
| DYAI | DYADIC INTERNATIONAL INC | SELL | 87% | View Analysis → |
| DRTSW | Alpha Tau Medical Ltd. | SELL | 87% | View Analysis → |
| CURX | Curanex Pharmaceuticals Inc | SELL | 87% | View Analysis → |
| CTMX | CytomX Therapeutics, Inc. | STRONG SELL | 87% | View Analysis → |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | SELL | 87% | View Analysis → |
| CLPT | ClearPoint Neuro, Inc. | SELL | 87% | View Analysis → |
| CELC | Celcuity Inc. | SELL | 87% | View Analysis → |
| CADL | Candel Therapeutics, Inc. | SELL | 87% | View Analysis → |
| CABA | Cabaletta Bio, Inc. | SELL | 87% | View Analysis → |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | SELL | 87% | View Analysis → |
| ATEC | Alphatec Holdings, Inc. | SELL | 87% | View Analysis → |
| ANRO | Alto Neuroscience, Inc. | SELL | 87% | View Analysis → |
| IMNN | Imunon, Inc. | STRONG SELL | 86% | View Analysis → |
| HSTC | HST Global, Inc. | STRONG SELL | 86% | View Analysis → |
| GRST | ETHEMA HEALTH Corp | STRONG SELL | 86% | View Analysis → |
| GOVX | GeoVax Labs, Inc. | STRONG SELL | 86% | View Analysis → |
| RMHI | Retrieve Medical Holdings, Inc. | STRONG SELL | 86% | View Analysis → |
| NSPR | InspireMD, Inc. | STRONG SELL | 86% | View Analysis → |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | SELL | 86% | View Analysis → |
| LUNG | Pulmonx Corp | SELL | 86% | View Analysis → |
| LXEO | Lexeo Therapeutics, Inc. | SELL | 86% | View Analysis → |
| IRON | Disc Medicine, Inc. | SELL | 86% | View Analysis → |
| INTS | INTENSITY THERAPEUTICS, INC. | SELL | 86% | View Analysis → |
| FULC | Fulcrum Therapeutics, Inc. | SELL | 86% | View Analysis → |
| ESMC | ESCALON MEDICAL CORP | SELL | 86% | View Analysis → |
| ELDN | Eledon Pharmaceuticals, Inc. | SELL | 86% | View Analysis → |
| DYNTQ | DYNATRONICS CORP | SELL | 86% | View Analysis → |
| DSGN | Design Therapeutics, Inc. | SELL | 86% | View Analysis → |
| DNLI | Denali Therapeutics Inc. | SELL | 86% | View Analysis → |
| CRNX | Crinetics Pharmaceuticals, Inc. | SELL | 86% | View Analysis → |
| CPRX | CATALYST PHARMACEUTICALS, INC. | BUY | 86% | View Analysis → |
| CNTN | Canton Strategic Holdings, Inc. | SELL | 86% | View Analysis → |
| CNTA | Centessa Pharmaceuticals plc | SELL | 86% | View Analysis → |
| CCEL | CRYO CELL INTERNATIONAL INC | STRONG SELL | 86% | View Analysis → |
| BOLD | Boundless Bio, Inc. | SELL | 86% | View Analysis → |
| BNTC | Benitec Biopharma Inc. | SELL | 86% | View Analysis → |
| AVBP | ArriVent BioPharma, Inc. | SELL | 86% | View Analysis → |
| APRE | Aprea Therapeutics, Inc. | STRONG SELL | 86% | View Analysis → |
| SYK | STRYKER CORP | BUY | 86% | View Analysis → |
| ALLO | Allogene Therapeutics, Inc. | SELL | 86% | View Analysis → |
| SSII | SS Innovations International, Inc. | STRONG SELL | 85% | View Analysis → |
| SRPT | Sarepta Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| SNNC | Sibannac, Inc. | STRONG SELL | 85% | View Analysis → |
| SMMT | Summit Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| SI | SHOULDER INNOVATIONS, INC. | STRONG SELL | 85% | View Analysis → |
| SER | Serina Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| RZLT | Rezolute, Inc. | STRONG SELL | 85% | View Analysis → |
| RCKTW | ROCKET PHARMACEUTICALS, INC. | STRONG SELL | 85% | View Analysis → |
| QNRX | Quoin Pharmaceuticals, Ltd. | STRONG SELL | 85% | View Analysis → |
| QDEL | QuidelOrtho Corp | STRONG SELL | 85% | View Analysis → |
| PYXS | Pyxis Oncology, Inc. | STRONG SELL | 85% | View Analysis → |
| PTHS | Pelthos Therapeutics Inc. | STRONG SELL | 85% | View Analysis → |
| PSNL | Personalis, Inc. | SELL | 85% | View Analysis → |
| PROK | PROKIDNEY CORP. | STRONG SELL | 85% | View Analysis → |
| PDSB | PDS Biotechnology Corp | STRONG SELL | 85% | View Analysis → |
| PCVX | Vaxcyte, Inc. | STRONG SELL | 85% | View Analysis → |
| OWPC | One World Products, Inc. | STRONG SELL | 85% | View Analysis → |
| ONCY | ONCOLYTICS BIOTECH INC | STRONG SELL | 85% | View Analysis → |
| NXGLW | NEXGEL, INC. | SELL | 85% | View Analysis → |
| LIPO | LIPELLA PHARMACEUTICALS INC. | STRONG SELL | 85% | View Analysis → |
| NRXS | Neuraxis, INC | STRONG SELL | 85% | View Analysis → |
| MDNAF | Medicenna Therapeutics Corp. | SELL | 85% | View Analysis → |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | SELL | 85% | View Analysis → |
| MCRB | Seres Therapeutics, Inc. | STRONG SELL | 85% | View Analysis → |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | SELL | 85% | View Analysis → |
| INSP | Inspire Medical Systems, Inc. | BUY | 85% | View Analysis → |
| FDMT | 4D Molecular Therapeutics, Inc. | SELL | 85% | View Analysis → |
| ENLV | Enlivex Ltd. | SELL | 85% | View Analysis → |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | SELL | 85% | View Analysis → |
| CVRX | CVRx, Inc. | SELL | 85% | View Analysis → |
| CMPX | Compass Therapeutics, Inc. | SELL | 85% | View Analysis → |
| CHRS | Coherus Oncology, Inc. | SELL | 85% | View Analysis → |
| CGEM | Cullinan Therapeutics, Inc. | SELL | 85% | View Analysis → |
| NBIX | NEUROCRINE BIOSCIENCES INC | BUY | 84% | View Analysis → |
| LTRN | Lantern Pharma Inc. | STRONG SELL | 84% | View Analysis → |
| LITS | Lite Strategy, Inc. | SELL | 84% | View Analysis → |
| IMDX | Insight Molecular Diagnostics Inc. | STRONG SELL | 84% | View Analysis → |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | STRONG SELL | 84% | View Analysis → |
| MBX | MBX Biosciences, Inc. | SELL | 84% | View Analysis → |
| MAZE | Maze Therapeutics, Inc. | SELL | 84% | View Analysis → |
| LXRX | LEXICON PHARMACEUTICALS, INC. | SELL | 84% | View Analysis → |
| IRIX | IRIDEX CORP | SELL | 84% | View Analysis → |
| IPHYF | Innate Pharma SA | SELL | 84% | View Analysis → |
| IONS | IONIS PHARMACEUTICALS INC | SELL | 84% | View Analysis → |
| GERN | GERON CORP | SELL | 84% | View Analysis → |
| FLGT | Fulgent Genetics, Inc. | SELL | 84% | View Analysis → |
| ENGNW | enGene Holdings Inc. | SELL | 84% | View Analysis → |
| ELTP | ELITE PHARMACEUTICALS INC /NV/ | BUY | 84% | View Analysis → |
| EDSA | Edesa Biotech, Inc. | SELL | 84% | View Analysis → |
| ECIA | ENCISION INC | SELL | 84% | View Analysis → |
| DYN | Dyne Therapeutics, Inc. | SELL | 84% | View Analysis → |
| DTIL | PRECISION BIOSCIENCES INC | SELL | 84% | View Analysis → |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | SELL | 84% | View Analysis → |
| CVSI | CV Sciences, Inc. | STRONG SELL | 84% | View Analysis → |
| CUE | Cue Biopharma, Inc. | SELL | 84% | View Analysis → |
| CTSO | Cytosorbents Corp | SELL | 84% | View Analysis → |
| CTNM | Contineum Therapeutics, Inc. | SELL | 84% | View Analysis → |
| CNTX | Context Therapeutics Inc. | SELL | 84% | View Analysis → |
| CGTX | COGNITION THERAPEUTICS INC | SELL | 84% | View Analysis → |
| CCCC | C4 Therapeutics, Inc. | SELL | 84% | View Analysis → |
| CBIO | CRESCENT BIOPHARMA, INC. | SELL | 84% | View Analysis → |
| CATX | Perspective Therapeutics, Inc. | SELL | 84% | View Analysis → |
| BRNS | Barinthus Biotherapeutics plc. | SELL | 84% | View Analysis → |
| BLTE | BELITE BIO, INC | SELL | 84% | View Analysis → |
| BIOA | BioAge Labs, Inc. | SELL | 84% | View Analysis → |
| BHST | BIOHARVEST SCIENCES INC. | SELL | 84% | View Analysis → |
| BFRIW | Biofrontera Inc. | SELL | 84% | View Analysis → |
| BEIGF | BeOne Medicines Ltd. | BUY | 84% | View Analysis → |
| BDMDW | Baird Medical Investment Holdings Ltd | SELL | 84% | View Analysis → |
| AVIR | Atea Pharmaceuticals, Inc. | SELL | 84% | View Analysis → |
| AUTL | Autolus Therapeutics plc | SELL | 84% | View Analysis → |
| AURA | Aura Biosciences, Inc. | SELL | 84% | View Analysis → |
| VTRS | Viatris Inc | SELL | 84% | View Analysis → |
| CNC | CENTENE CORP | SELL | 84% | View Analysis → |
| ANEB | Anebulo Pharmaceuticals, Inc. | SELL | 84% | View Analysis → |
| OGEN | ORAGENICS INC | STRONG SELL | 83% | View Analysis → |
| LIXT | LIXTE BIOTECHNOLOGY HOLDINGS, INC. | SELL | 83% | View Analysis → |
| HUMAW | Humacyte, Inc. | STRONG SELL | 83% | View Analysis → |
| HIND | Vyome Holdings, Inc | SELL | 83% | View Analysis → |
| GTBP | GT Biopharma, Inc. | STRONG SELL | 83% | View Analysis → |
| MRKR | Marker Therapeutics, Inc. | SELL | 83% | View Analysis → |
| IRMD | IRADIMED CORP | BUY | 83% | View Analysis → |
| FZMD | Fuse Medical, Inc. | SELL | 83% | View Analysis → |
| EWTX | Edgewise Therapeutics, Inc. | SELL | 83% | View Analysis → |
| EVAX | Evaxion A/S | SELL | 83% | View Analysis → |
| CGON | CG Oncology, Inc. | SELL | 83% | View Analysis → |
| BCTXZ | BriaCell Therapeutics Corp. | SELL | 83% | View Analysis → |
| OGN | Organon & Co. | SELL | 83% | View Analysis → |
| ALDX | Aldeyra Therapeutics, Inc. | SELL | 83% | View Analysis → |
| SCYX | SCYNEXIS INC | SELL | 82% | View Analysis → |
| RSMDF | RESMED INC | STRONG BUY | 82% | View Analysis → |
| PLSE | PULSE BIOSCIENCES, INC. | STRONG SELL | 82% | View Analysis → |
| OSUR | ORASURE TECHNOLOGIES INC | SELL | 82% | View Analysis → |
| NXL | Nexalin Technology, Inc. | STRONG SELL | 82% | View Analysis → |
| MTVA | MetaVia Inc. | SELL | 82% | View Analysis → |
| LSTA | LISATA THERAPEUTICS, INC. | STRONG SELL | 82% | View Analysis → |
| JSPRW | Jasper Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| HYPD | HYPERION DEFI, INC. | STRONG SELL | 82% | View Analysis → |
| HOWL | Werewolf Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| GNPX | Genprex, Inc. | STRONG SELL | 82% | View Analysis → |
| RNAZ | Transcode Therapeutics, Inc. | STRONG SELL | 82% | View Analysis → |
| NNVC | NANOVIRICIDES, INC. | SELL | 82% | View Analysis → |
| NMRA | Neumora Therapeutics, Inc. | SELL | 82% | View Analysis → |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | SELL | 82% | View Analysis → |
| MNOV | MEDICINOVA INC | SELL | 82% | View Analysis → |
| JANX | Janux Therapeutics, Inc. | SELL | 82% | View Analysis → |
| EXEL | EXELIXIS, INC. | BUY | 82% | View Analysis → |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | SELL | 82% | View Analysis → |
| ELVN | Enliven Therapeutics, Inc. | SELL | 82% | View Analysis → |
| CRSP | CRISPR Therapeutics AG | SELL | 82% | View Analysis → |
| CLOV | CLOVER HEALTH INVESTMENTS, CORP. /DE | SELL | 82% | View Analysis → |
| CHE | CHEMED CORP | BUY | 82% | View Analysis → |
| CAPR | CAPRICOR THERAPEUTICS, INC. | SELL | 82% | View Analysis → |
| CAMP | Camp4 Therapeutics Corp | SELL | 82% | View Analysis → |
| BHC | Bausch Health Companies Inc. | SELL | 82% | View Analysis → |
| BCYC | BICYCLE THERAPEUTICS PLC | SELL | 82% | View Analysis → |
| BCAX | Bicara Therapeutics Inc. | SELL | 82% | View Analysis → |
| ARDX | ARDELYX, INC. | SELL | 82% | View Analysis → |
| APGE | Apogee Therapeutics, Inc. | SELL | 82% | View Analysis → |
| INCY | INCYTE CORP | BUY | 82% | View Analysis → |
| BDX | BECTON DICKINSON & CO | SELL | 82% | View Analysis → |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | BUY | 82% | View Analysis → |
| ROIV | Roivant Sciences Ltd. | SELL | 81% | View Analysis → |
| NTLA | Intellia Therapeutics, Inc. | SELL | 81% | View Analysis → |
| EQ | Equillium, Inc. | SELL | 81% | View Analysis → |
| AVXL | ANAVEX LIFE SCIENCES CORP. | SELL | 81% | View Analysis → |
| ATOS | ATOSSA THERAPEUTICS, INC. | SELL | 81% | View Analysis → |
| AHCO | AdaptHealth Corp. | SELL | 81% | View Analysis → |
| PASG | Passage BIO, Inc. | STRONG SELL | 80% | View Analysis → |
| LPCN | Lipocine Inc. | SELL | 80% | View Analysis → |
| LMAT | LEMAITRE VASCULAR INC | BUY | 80% | View Analysis → |
| KRYS | Krystal Biotech, Inc. | BUY | 80% | View Analysis → |
| KOD | Kodiak Sciences Inc. | SELL | 80% | View Analysis → |
| IGC | IGC Pharma, Inc. | SELL | 80% | View Analysis → |
| IBIO | iBio, Inc. | STRONG SELL | 80% | View Analysis → |
| GRI | GRI Bio, Inc. | SELL | 80% | View Analysis → |
| MPLT | MapLight Therapeutics, Inc. | SELL | 80% | View Analysis → |
| MMSI | MERIT MEDICAL SYSTEMS INC | BUY | 80% | View Analysis → |
| FBIOP | Fortress Biotech, Inc. | SELL | 80% | View Analysis → |
| ELMD | Electromed, Inc. | BUY | 80% | View Analysis → |
| DAWN | Day One Biopharmaceuticals, Inc. | SELL | 80% | View Analysis → |
| CYH | COMMUNITY HEALTH SYSTEMS INC | SELL | 80% | View Analysis → |
| COYA | Coya Therapeutics, Inc. | SELL | 80% | View Analysis → |
| COLL | COLLEGIUM PHARMACEUTICAL, INC | BUY | 80% | View Analysis → |
| CMMB | Chemomab Therapeutics Ltd. | SELL | 80% | View Analysis → |
| CBLL | Ceribell, Inc. | SELL | 80% | View Analysis → |
| CARL | CARLSMED, INC. | SELL | 80% | View Analysis → |
| BEAM | Beam Therapeutics Inc. | SELL | 80% | View Analysis → |
| BBNX | Beta Bionics, Inc. | SELL | 80% | View Analysis → |
| ARCT | Arcturus Therapeutics Holdings Inc. | SELL | 80% | View Analysis → |
| REGN | REGENERON PHARMACEUTICALS, INC. | BUY | 80% | View Analysis → |
| MRK | Merck & Co., Inc. | BUY | 80% | View Analysis → |
| MDT | Medtronic plc | BUY | 80% | View Analysis → |
| BSX | BOSTON SCIENTIFIC CORP | BUY | 80% | View Analysis → |
| BAX | BAXTER INTERNATIONAL INC | SELL | 80% | View Analysis → |
| LDDD | Longduoduo Co Ltd | SELL | 79% | View Analysis → |
| KYNB | KYNTRA BIO, INC. | SELL | 79% | View Analysis → |
| HRMY | Harmony Biosciences Holdings, Inc. | BUY | 79% | View Analysis → |
| GRDX | GridAI Technologies Corp. | SELL | 79% | View Analysis → |
| MLTX | MoonLake Immunotherapeutics | SELL | 79% | View Analysis → |
| INDV | Indivior Pharmaceuticals, Inc. | SELL | 79% | View Analysis → |
| FENC | FENNEC PHARMACEUTICALS INC. | SELL | 79% | View Analysis → |
| SRRK | Scholar Rock Holding Corp | SELL | 78% | View Analysis → |
| SGHT | Sight Sciences, Inc. | SELL | 78% | View Analysis → |
| SBFMW | Sunshine Biopharma Inc. | SELL | 78% | View Analysis → |
| SABSW | SAB Biotherapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | SELL | 78% | View Analysis → |
| RCUS | Arcus Biosciences, Inc. | SELL | 78% | View Analysis → |
| RAPP | Rapport Therapeutics, Inc. | STRONG SELL | 78% | View Analysis → |
| PVLA | PALVELLA THERAPEUTICS, INC. | HOLD | 78% | View Analysis → |
| PTPI | Petros Pharmaceuticals, Inc. | STRONG SELL | 78% | View Analysis → |
| PTGX | Protagonist Therapeutics, Inc | SELL | 78% | View Analysis → |
| PRME | Prime Medicine, Inc. | STRONG SELL | 78% | View Analysis → |
| PMCB | PharmaCyte Biotech, Inc. | SELL | 78% | View Analysis → |
| PLYX | Polaryx Therapeutics, Inc. | SELL | 78% | View Analysis → |
| PGNY | Progyny, Inc. | BUY | 78% | View Analysis → |
| PEN | Penumbra Inc | BUY | 78% | View Analysis → |
| OPK | OPKO HEALTH, INC. | SELL | 78% | View Analysis → |
| OABIW | OmniAb, Inc. | SELL | 78% | View Analysis → |
| NXTC | NextCure, Inc. | SELL | 78% | View Analysis → |
| NEOG | NEOGEN CORP | SELL | 78% | View Analysis → |
| NAMSW | NewAmsterdam Pharma Co N.V. | SELL | 78% | View Analysis → |
| MYGN | MYRIAD GENETICS INC | SELL | 78% | View Analysis → |
| LFCR | LIFECORE BIOMEDICAL, INC. DE | SELL | 78% | View Analysis → |
| KPHMW | KIORA PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| JBIO | Jade Biosciences, Inc. | SELL | 78% | View Analysis → |
| IMA | ImageneBio, Inc. | SELL | 78% | View Analysis → |
| GMED | GLOBUS MEDICAL INC | BUY | 78% | View Analysis → |
| GIPL | Global Innovative Platforms Inc. | SELL | 78% | View Analysis → |
| RNAC | Cartesian Therapeutics, Inc. | SELL | 78% | View Analysis → |
| RLAY | Relay Therapeutics, Inc. | SELL | 78% | View Analysis → |
| NUVL | Nuvalent, Inc. | SELL | 78% | View Analysis → |
| NUVB | Nuvation Bio Inc. | SELL | 78% | View Analysis → |
| MREO | Mereo BioPharma Group plc | SELL | 78% | View Analysis → |
| MLYS | Mineralys Therapeutics, Inc. | SELL | 78% | View Analysis → |
| IVVD | Invivyd, Inc. | SELL | 78% | View Analysis → |
| IPSC | Century Therapeutics, Inc. | SELL | 78% | View Analysis → |
| INFU | InfuSystem Holdings, Inc | BUY | 78% | View Analysis → |
| ENTA | ENANTA PHARMACEUTICALS INC | SELL | 78% | View Analysis → |
| ELAN | Elanco Animal Health Inc | SELL | 78% | View Analysis → |
| CSTL | CASTLE BIOSCIENCES INC | SELL | 78% | View Analysis → |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | SELL | 78% | View Analysis → |
| CORT | CORCEPT THERAPEUTICS INC | BUY | 78% | View Analysis → |
| CLYM | Climb Bio, Inc. | SELL | 78% | View Analysis → |
| CERS | CERUS CORP | SELL | 78% | View Analysis → |
| BMRN | BIOMARIN PHARMACEUTICAL INC | BUY | 78% | View Analysis → |
| AYTU | AYTU BIOPHARMA, INC | SELL | 78% | View Analysis → |
| AXGN | Axogen, Inc. | SELL | 78% | View Analysis → |
| ARVN | ARVINAS, INC. | SELL | 78% | View Analysis → |
| ZTS | Zoetis Inc. | BUY | 78% | View Analysis → |
| WST | WEST PHARMACEUTICAL SERVICES INC | BUY | 78% | View Analysis → |
| UHS | UNIVERSAL HEALTH SERVICES INC | BUY | 78% | View Analysis → |
| AMRN | AMARIN CORP PLCUK | SELL | 78% | View Analysis → |
| LONA | LeonaBio, Inc. | SELL | 77% | View Analysis → |
| RMTI | ROCKWELL MEDICAL, INC. | SELL | 77% | View Analysis → |
| ESPR | Esperion Therapeutics, Inc. | SELL | 77% | View Analysis → |
| DGX | QUEST DIAGNOSTICS INC | BUY | 77% | View Analysis → |
| ABT | ABBOTT LABORATORIES | BUY | 77% | View Analysis → |
| ORIC | Oric Pharmaceuticals, Inc. | SELL | 76% | View Analysis → |
| OMDA | Omada Health, Inc. | BUY | 76% | View Analysis → |
| NVNO | enVVeno Medical Corp | STRONG SELL | 76% | View Analysis → |
| NERV | Minerva Neurosciences, Inc. | SELL | 76% | View Analysis → |
| NEPH | NEPHROS INC | BUY | 76% | View Analysis → |
| LH | LABCORP HOLDINGS INC. | BUY | 76% | View Analysis → |
| LCTX | Lineage Cell Therapeutics, Inc. | SELL | 76% | View Analysis → |
| KYMR | Kymera Therapeutics, Inc. | SELL | 76% | View Analysis → |
| KAPA | Kairos Pharma, LTD. | SELL | 76% | View Analysis → |
| IMNM | Immunome Inc. | SELL | 76% | View Analysis → |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | SELL | 76% | View Analysis → |
| GRAL | GRAIL, Inc. | SELL | 76% | View Analysis → |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | SELL | 76% | View Analysis → |
| MRNA | Moderna, Inc. | SELL | 76% | View Analysis → |
| JAZZ | Jazz Pharmaceuticals plc | SELL | 76% | View Analysis → |
| EHAB | Enhabit, Inc. | SELL | 76% | View Analysis → |
| DCTH | DELCATH SYSTEMS, INC. | BUY | 76% | View Analysis → |
| CSBR | CHAMPIONS ONCOLOGY, INC. | SELL | 76% | View Analysis → |
| CFOR | CapForce Inc. | SELL | 76% | View Analysis → |
| CELG-RI | BRISTOL MYERS SQUIBB CO | BUY | 76% | View Analysis → |
| BLLN | BillionToOne, Inc. | BUY | 76% | View Analysis → |
| AXSM | Axsome Therapeutics, Inc. | SELL | 76% | View Analysis → |
| AUPH | Aurinia Pharmaceuticals Inc. | BUY | 76% | View Analysis → |
| ARQT | Arcutis Biotherapeutics, Inc. | SELL | 76% | View Analysis → |
| UNH | UNITEDHEALTH GROUP INC | BUY | 76% | View Analysis → |
| CI | Cigna Group | BUY | 76% | View Analysis → |
| ANGO | ANGIODYNAMICS INC | SELL | 76% | View Analysis → |
| AMPH | Amphastar Pharmaceuticals, Inc. | BUY | 76% | View Analysis → |
| ALKS | Alkermes plc. | BUY | 76% | View Analysis → |
| SKIN | Beauty Health Co | SELL | 75% | View Analysis → |
| SIGA | SIGA TECHNOLOGIES INC | HOLD | 75% | View Analysis → |
| RXRX | RECURSION PHARMACEUTICALS, INC. | SELL | 75% | View Analysis → |
| RPRX | Royalty Pharma plc | HOLD | 75% | View Analysis → |
| PROF | Profound Medical Corp. | SELL | 75% | View Analysis → |
| PMDI | PSYCHEMEDICS CORP | SELL | 75% | View Analysis → |
| PCYN | PROCYON CORP | SELL | 75% | View Analysis → |
| OPCH | Option Care Health, Inc. | BUY | 75% | View Analysis → |
| LRMR | Larimar Therapeutics, Inc. | SELL | 75% | View Analysis → |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | SELL | 75% | View Analysis → |
| GLSI | Greenwich LifeSciences, Inc. | STRONG SELL | 75% | View Analysis → |
| ELV | Elevance Health, Inc. | BUY | 75% | View Analysis → |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | SELL | 75% | View Analysis → |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | SELL | 75% | View Analysis → |
| HCA | HCA Healthcare, Inc. | BUY | 75% | View Analysis → |
| AMS | AMERICAN SHARED HOSPITAL SERVICES | SELL | 75% | View Analysis → |
| OVID | Ovid Therapeutics Inc. | SELL | 74% | View Analysis → |
| OM | Outset Medical, Inc. | SELL | 74% | View Analysis → |
| OKUR | OnKure Therapeutics, Inc. | SELL | 74% | View Analysis → |
| OBIO | Orchestra BioMed Holdings, Inc. | SELL | 74% | View Analysis → |
| NVCT | Nuvectis Pharma, Inc. | SELL | 74% | View Analysis → |
| NGNE | Neurogene Inc. | SELL | 74% | View Analysis → |
| LGNZZ | LIGAND PHARMACEUTICALS INC | BUY | 74% | View Analysis → |
| LENZ | LENZ Therapeutics, Inc. | SELL | 74% | View Analysis → |
| KYTX | Kyverna Therapeutics, Inc. | SELL | 74% | View Analysis → |
| KRRO | Korro Bio, Inc. | SELL | 74% | View Analysis → |
| HSIC | HENRY SCHEIN INC | BUY | 74% | View Analysis → |
| RNXT | RenovoRx, Inc. | SELL | 74% | View Analysis → |
| REPL | Replimune Group, Inc. | STRONG SELL | 74% | View Analysis → |
| RDNT | RadNet, Inc. | SELL | 74% | View Analysis → |
| MNPR | Monopar Therapeutics | SELL | 74% | View Analysis → |
| CNMD | CONMED Corp | SELL | 74% | View Analysis → |
| BDTX | Black Diamond Therapeutics, Inc. | BUY | 74% | View Analysis → |
| APLS | Apellis Pharmaceuticals, Inc. | BUY | 74% | View Analysis → |
| IQV | IQVIA HOLDINGS INC. | BUY | 74% | View Analysis → |
| ANIP | ANI PHARMACEUTICALS INC | BUY | 74% | View Analysis → |
| PDEX | PRO DEX INC | BUY | 73% | View Analysis → |
| KROS | Keros Therapeutics, Inc. | BUY | 73% | View Analysis → |
| GPCR | Structure Therapeutics Inc. | SELL | 73% | View Analysis → |
| SRTS | Sensus Healthcare, Inc. | SELL | 72% | View Analysis → |
| SNWV | SANUWAVE Health, Inc. | SELL | 72% | View Analysis → |
| SNDX | Syndax Pharmaceuticals Inc | SELL | 72% | View Analysis → |
| SHC | Sotera Health Co | HOLD | 72% | View Analysis → |
| SGRY | Surgery Partners, Inc. | HOLD | 72% | View Analysis → |
| SDGR | Schrodinger, Inc. | SELL | 72% | View Analysis → |
| SANA | Sana Biotechnology, Inc. | SELL | 72% | View Analysis → |
| RARE | Ultragenyx Pharmaceutical Inc. | SELL | 72% | View Analysis → |
| PRGO | PERRIGO Co plc | SELL | 72% | View Analysis → |
| PRCT | PROCEPT BioRobotics Corp | SELL | 72% | View Analysis → |
| PODD | INSULET CORP | BUY | 72% | View Analysis → |
| PFE | PFIZER INC | SELL | 72% | View Analysis → |
| PEPG | PepGen Inc. | SELL | 72% | View Analysis → |
| PBYI | PUMA BIOTECHNOLOGY, INC. | BUY | 72% | View Analysis → |
| ORKA | Oruka Therapeutics, Inc. | SELL | 72% | View Analysis → |
| OCUL | OCULAR THERAPEUTIX, INC | SELL | 72% | View Analysis → |
| MXCT | MAXCYTE, INC. | SELL | 72% | View Analysis → |
| LNTH | Lantheus Holdings, Inc. | BUY | 72% | View Analysis → |
| LIFD | LFTD PARTNERS INC. | SELL | 72% | View Analysis → |
| LIANY | LianBio | SELL | 72% | View Analysis → |
| HYPR | Hyperfine, Inc. | SELL | 72% | View Analysis → |
| HOTH | Hoth Therapeutics, Inc. | SELL | 72% | View Analysis → |
| GRTX | Galera Therapeutics, Inc. | SELL | 72% | View Analysis → |
| REVBW | REVELATION BIOSCIENCES, INC. | SELL | 72% | View Analysis → |
| NRIX | Nurix Therapeutics, Inc. | SELL | 72% | View Analysis → |
| MIRM | Mirum Pharmaceuticals, Inc. | BUY | 72% | View Analysis → |
| MDNC | Medinotec Inc. | BUY | 72% | View Analysis → |
| MDLN | Medline Inc. | BUY | 72% | View Analysis → |
| EBS | Emergent BioSolutions Inc. | BUY | 72% | View Analysis → |
| BCRX | BIOCRYST PHARMACEUTICALS INC | BUY | 72% | View Analysis → |
| NVCR | NovoCure Ltd | SELL | 71% | View Analysis → |
| HAE | HAEMONETICS CORP | BUY | 71% | View Analysis → |
| RLYB | Rallybio Corp | SELL | 71% | View Analysis → |
| RLMD | RELMADA THERAPEUTICS, INC. | STRONG SELL | 71% | View Analysis → |
| NPCE | NeuroPace Inc | SELL | 71% | View Analysis → |
| CNO-PA | CNO Financial Group, Inc. | HOLD | 71% | View Analysis → |
| BTSGU | BrightSpring Health Services, Inc. | HOLD | 71% | View Analysis → |
| SOLV | Solventum Corp | HOLD | 70% | View Analysis → |
| PTCT | PTC THERAPEUTICS, INC. | HOLD | 70% | View Analysis → |
| PRLD | Prelude Therapeutics Inc | SELL | 70% | View Analysis → |
| NKTX | Nkarta, Inc. | SELL | 70% | View Analysis → |
| NATR | NATURES SUNSHINE PRODUCTS INC | HOLD | 70% | View Analysis → |
| LEXX | Lexaria Bioscience Corp. | SELL | 70% | View Analysis → |
| LBRX | LB PHARMACEUTICALS INC | SELL | 70% | View Analysis → |
| KZR | Kezar Life Sciences, Inc. | SELL | 70% | View Analysis → |
| KIDS | ORTHOPEDIATRICS CORP | SELL | 70% | View Analysis → |
| ICCC | IMMUCELL CORP /DE/ | BUY | 70% | View Analysis → |
| RFL | Rafael Holdings, Inc. | SELL | 70% | View Analysis → |
| MASI | MASIMO CORP | HOLD | 70% | View Analysis → |
| ITGR | Integer Holdings Corp | HOLD | 70% | View Analysis → |
| IRWD | IRONWOOD PHARMACEUTICALS INC | HOLD | 70% | View Analysis → |
| IRTC | iRhythm Holdings, Inc. | HOLD | 70% | View Analysis → |
| FONR | FONAR CORP | HOLD | 70% | View Analysis → |
| EXAS | EXACT SCIENCES CORP | HOLD | 70% | View Analysis → |
| EMBC | Embecta Corp. | HOLD | 70% | View Analysis → |
| EHC | Encompass Health Corp | BUY | 70% | View Analysis → |
| DVA | DAVITA INC. | HOLD | 70% | View Analysis → |
| MMM | 3M CO | HOLD | 70% | View Analysis → |
| HUM | HUMANA INC | HOLD | 70% | View Analysis → |
| ALHC | Alignment Healthcare, Inc. | HOLD | 70% | View Analysis → |
| OLMA | Olema Pharmaceuticals, Inc. | SELL | 69% | View Analysis → |
| KURA | Kura Oncology, Inc. | SELL | 69% | View Analysis → |
| IKT | Inhibikase Therapeutics, Inc. | SELL | 69% | View Analysis → |
| HROW | HARROW, INC. | BUY | 69% | View Analysis → |
| GRCE | Grace Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| GLUE | Monte Rosa Therapeutics, Inc. | HOLD | 69% | View Analysis → |
| CDNA | CareDx, Inc. | HOLD | 69% | View Analysis → |
| CAI | Caris Life Sciences, Inc. | BUY | 69% | View Analysis → |
| AVAH | Aveanna Healthcare Holdings, Inc. | HOLD | 69% | View Analysis → |
| ARDT | Ardent Health, Inc. | HOLD | 69% | View Analysis → |
| AORT | ARTIVION, INC. | HOLD | 69% | View Analysis → |
| AMRX | Amneal Pharmaceuticals, Inc. | HOLD | 69% | View Analysis → |
| SPRO | Spero Therapeutics, Inc. | BUY | 68% | View Analysis → |
| SNSE | Sensei Biotherapeutics, Inc. | SELL | 68% | View Analysis → |
| SLNO | SOLENO THERAPEUTICS INC | HOLD | 68% | View Analysis → |
| SION | Sionna Therapeutics, Inc. | SELL | 68% | View Analysis → |
| SEM | SELECT MEDICAL HOLDINGS CORP | SELL | 68% | View Analysis → |
| QTTB | Q32 Bio Inc. | HOLD | 68% | View Analysis → |
| PRVA | Privia Health Group, Inc. | HOLD | 68% | View Analysis → |
| PLRX | PLIANT THERAPEUTICS, INC. | STRONG SELL | 68% | View Analysis → |
| PFHO | PACIFIC HEALTH CARE ORGANIZATION INC | HOLD | 68% | View Analysis → |
| PALI | PALISADE BIO, INC. | SELL | 68% | View Analysis → |
| OSCR | Oscar Health, Inc. | SELL | 68% | View Analysis → |
| OFIX | Orthofix Medical Inc. | SELL | 68% | View Analysis → |
| LIVN | LivaNova PLC | HOLD | 68% | View Analysis → |
| LFST | LifeStance Health Group, Inc. | SELL | 68% | View Analysis → |
| INBP | INTEGRATED BIOPHARMA INC | SELL | 68% | View Analysis → |
| IMRX | Immuneering Corp | SELL | 68% | View Analysis → |
| IMMX | Immix Biopharma, Inc. | SELL | 68% | View Analysis → |
| IDYA | IDEAYA Biosciences, Inc. | BUY | 68% | View Analysis → |
| ICUI | ICU MEDICAL INC/DE | SELL | 68% | View Analysis → |
| GKOS | GLAUKOS Corp | SELL | 68% | View Analysis → |
| NTRA | Natera, Inc. | BUY | 68% | View Analysis → |
| FOLD | AMICUS THERAPEUTICS, INC. | BUY | 68% | View Analysis → |
| CYRX | Cryoport, Inc. | SELL | 68% | View Analysis → |
| BVS | Bioventus Inc. | HOLD | 68% | View Analysis → |
| BIIB | BIOGEN INC. | HOLD | 68% | View Analysis → |
| ATRC | AtriCure, Inc. | BUY | 68% | View Analysis → |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | HOLD | 68% | View Analysis → |
| PFG | PRINCIPAL FINANCIAL GROUP INC | HOLD | 68% | View Analysis → |
| ANIK | Anika Therapeutics, Inc. | HOLD | 68% | View Analysis → |
| SIBN | SI-BONE, Inc. | BUY | 67% | View Analysis → |
| SEPN | Septerna, Inc. | BUY | 67% | View Analysis → |
| ORMP | ORAMED PHARMACEUTICALS INC. | SELL | 67% | View Analysis → |
| NVAX | NOVAVAX INC | SELL | 67% | View Analysis → |
| LFVN | Lifevantage Corp | SELL | 67% | View Analysis → |
| KTTAW | Pasithea Therapeutics Corp. | SELL | 67% | View Analysis → |
| KRMD | KORU Medical Systems, Inc. | BUY | 67% | View Analysis → |
| KNSA | Kiniksa Pharmaceuticals International, plc | BUY | 67% | View Analysis → |
| RIGL | RIGEL PHARMACEUTICALS INC | HOLD | 67% | View Analysis → |
| INNV | InnovAge Holding Corp. | HOLD | 67% | View Analysis → |
| ETON | Eton Pharmaceuticals, Inc. | BUY | 67% | View Analysis → |
| BLFS | BIOLIFE SOLUTIONS INC | BUY | 67% | View Analysis → |
| ANAB | ANAPTYSBIO, INC | HOLD | 67% | View Analysis → |
| NEUP | Neuphoria Therapeutics Inc. | SELL | 66% | View Analysis → |
| LQDA | Liquidia Corp | SELL | 66% | View Analysis → |
| IMVT | Immunovant, Inc. | SELL | 66% | View Analysis → |
| IMCR | Immunocore Holdings plc | BUY | 66% | View Analysis → |
| SPRB | SPRUCE BIOSCIENCES, INC. | SELL | 65% | View Analysis → |
| PHIO | Phio Pharmaceuticals Corp. | SELL | 65% | View Analysis → |
| PCRX | Pacira BioSciences, Inc. | HOLD | 65% | View Analysis → |
| PBH | Prestige Consumer Healthcare Inc. | BUY | 65% | View Analysis → |
| PAHC | PHIBRO ANIMAL HEALTH CORP | HOLD | 65% | View Analysis → |
| IDXG | INTERPACE BIOSCIENCES, INC. | HOLD | 65% | View Analysis → |
| ICUCW | SeaStar Medical Holding Corp | SELL | 65% | View Analysis → |
| RGEN | REPLIGEN CORP | HOLD | 65% | View Analysis → |
| ORGO | Organogenesis Holdings Inc. | HOLD | 64% | View Analysis → |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | HOLD | 64% | View Analysis → |
| HCIL | Hongchang International Co., Ltd | SELL | 64% | View Analysis → |
| HALO | HALOZYME THERAPEUTICS, INC. | BUY | 64% | View Analysis → |
| NRC | NATIONAL RESEARCH CORP | HOLD | 64% | View Analysis → |
| MOH | MOLINA HEALTHCARE, INC. | HOLD | 64% | View Analysis → |
| AKBA | Akebia Therapeutics, Inc. | HOLD | 64% | View Analysis → |
| GYRE | GYRE THERAPEUTICS, INC. | HOLD | 63% | View Analysis → |
| MNKD | MANNKIND CORP | HOLD | 63% | View Analysis → |
| MD | Pediatrix Medical Group, Inc. | HOLD | 62% | View Analysis → |
| KLRS | Kalaris Therapeutics, Inc. | SELL | 60% | View Analysis → |
| HTFL | Heartflow, Inc. | HOLD | 60% | View Analysis → |
| NNNN | Anbio Biotechnology | SELL | 60% | View Analysis → |
| PNTG | Pennant Group, Inc. | HOLD | 58% | View Analysis → |
| INAB | IN8BIO, INC. | SELL | 58% | View Analysis → |
| MSLE | Satellos Bioscience Inc. | SELL | 58% | View Analysis → |
| HOOK | HOOKIPA Pharma Inc. | SELL | 56% | View Analysis → |
| SRTAW | Strata Critical Medical, Inc. | HOLD | 55% | View Analysis → |
| KALV | KalVista Pharmaceuticals, Inc. | HOLD | 54% | View Analysis → |
| ETST | Earth Science Tech, Inc. | HOLD | 52% | View Analysis → |
| CANF | Can-Fite BioPharma Ltd. | SELL | 52% | View Analysis → |
| BLRX | BioLineRx Ltd. | SELL | 52% | View Analysis → |
| ARGX | ARGENX SE | BUY | 50% | View Analysis → |
| RANI | Rani Therapeutics Holdings, Inc. | SELL | 48% | View Analysis → |
| CGEN | COMPUGEN LTD | HOLD | 47% | View Analysis → |
| GENB | Generate Biomedicines, Inc. | SELL | 46% | View Analysis → |
| GDTC | CytoMed Therapeutics Ltd | SELL | 44% | View Analysis → |
| EVOTF | Evotec SE | SELL | 44% | View Analysis → |
| CLLS | Cellectis S.A. | SELL | 44% | View Analysis → |
| BNTX | BioNTech SE | HOLD | 44% | View Analysis → |
| BGM | BGM Group Ltd. | SELL | 44% | View Analysis → |
| AZN | ASTRAZENECA PLC | BUY | 44% | View Analysis → |
| ASND | Ascendis Pharma A/S | BUY | 44% | View Analysis → |
| INMD | InMode Ltd. | HOLD | 42% | View Analysis → |
| AKTS | Aktis Oncology, Inc. | HOLD | 42% | View Analysis → |
| FMCQF | Fresenius Medical Care AG | HOLD | 41% | View Analysis → |
| EIKN | Eikon Therapeutics, Inc. | HOLD | 41% | View Analysis → |
| GHRS | GH Research PLC | HOLD | 40% | View Analysis → |
| BRSYF | Brainsway Ltd. | BUY | 40% | View Analysis → |
| BNR | Burning Rock Biotech Ltd | HOLD | 40% | View Analysis → |
| ALVOW | Alvotech | HOLD | 40% | View Analysis → |
| EDAP | EDAP TMS SA | HOLD | 39% | View Analysis → |
| CRDL | Cardiol Therapeutics Inc. | HOLD | 39% | View Analysis → |
| RLFTF | Relief Therapeutics Holding SA | SELL | 32% | View Analysis → |
| RNA | Atrium Therapeutics, Inc. | SELL | 21% | View Analysis → |
| NRSNW | NeuroSense Therapeutics Ltd. | HOLD | 20% | View Analysis → |
| LMRI | Lumexa Imaging Holdings, Inc. | HOLD | 18% | View Analysis → |
| NSRX | Nasus Pharma Ltd | HOLD | 18% | View Analysis → |
| NONOF | NOVO NORDISK A S | HOLD | 18% | View Analysis → |
| MOLN | MOLECULAR PARTNERS AG | HOLD | 18% | View Analysis → |
| MMED | MiniMed Group, Inc. | SELL | 18% | View Analysis → |
| RDHL | RedHill Biopharma Ltd. | HOLD | 16% | View Analysis → |
| RDY | DR REDDYS LABORATORIES LTD | HOLD | 15% | View Analysis → |
| RDPTF | Radiopharm Theranostics Ltd | HOLD | 14% | View Analysis → |
| PARK | Park Dental Partners, Inc. | HOLD | 5% | View Analysis → |
| MEOBF | MESOBLAST LTD | HOLD | 5% | View Analysis → |
| MDXH | MDxHealth SA | HOLD | 5% | View Analysis → |
Frequently Asked Questions: Healthcare Stocks
What are the best healthcare stocks to buy in 2026?
Based on our dual AI fundamental analysis (Claude and ChatGPT), 93 healthcare stocks have Buy or Strong Buy ratings in 2026. These are ranked by confidence score based on SEC 10-K and 10-Q filing analysis.
Which healthcare stocks have Strong Buy ratings?
Currently, 5 healthcare stocks have a Strong Buy rating from our AI analysis. Strong Buy indicates both Claude and ChatGPT agree on exceptional fundamentals with high confidence scores above 80%.
How does AI analyze healthcare stocks?
Our dual AI system analyzes SEC EDGAR filings including revenue growth, profit margins, ROE, ROA, debt levels, and cash flow. Both Claude (Anthropic) and ChatGPT (OpenAI) independently evaluate each stock, then we combine their ratings for higher accuracy.
What is the AI confidence score?
AI confidence scores range from 0-100% and indicate how strongly the AI models agree on their rating. Higher confidence means clearer signals from SEC filing data. Healthcare stocks with 80%+ confidence have the most reliable ratings.
Should I invest in healthcare stocks in 2026?
Our AI analysis shows 93 Buy ratings vs 664 Sell ratings in the healthcare sector. Individual stock fundamentals vary significantly - review each stock's detailed analysis. This is not investment advice.
How often are healthcare stock ratings updated?
AI ratings are updated whenever companies file new SEC reports (10-K annually, 10-Q quarterly). Most healthcare stocks are re-analyzed within 24-48 hours of new filings being published on SEC EDGAR.
What data sources are used for healthcare stock analysis?
All analysis is based on official SEC EDGAR filings including Form 10-K (annual reports), Form 10-Q (quarterly reports), and other regulatory disclosures. We do not use price data or market sentiment - only fundamental financial data.